Phenotyping of Obesity Treatment Candidates: A Narrative Review

Research output: Contribution to journalReview articlepeer-review


Purpose of Review: This review explores characterizing candidates for obesity treatments including pharmacotherapy, endoscopic bariatric therapies, and metabolic bariatric surgery (MBS), focusing on established clinical parameters for diagnosing obesity beyond body mass index alone. Recent Findings: Existing literature primarily provides rates for fat mass percentage (i.e., a marker for adiposity quantity), waist circumference (i.e., a marker for adiposity distribution), and C-reactive protein levels (i.e., a marker for adiposity functionality) among obesity treatment candidates. Limited data on abnormal values and sex-based differentiation exist. The literature indicates high central-tendency measures for fat mass percentage and waist circumference, while C-reactive protein levels vary. Data on the Edmonton Obesity Staging System (i.e., a marker for adiposity-related disease severity) is predominantly available for MBS candidates. Summary: Future studies in obesity interventions should improve screening and diagnosis of obesity by incorporating sex-specific considerations and providing abnormal value rates for measurements to enhance understanding of patients' characteristics.

Original languageEnglish
JournalCurrent Obesity Reports
StateAccepted/In press - 2024


  • Adiposity
  • Anti-obesity medications
  • Endoscopic bariatric therapies
  • Metabolic bariatric surgery
  • Obesity diagnosis


Dive into the research topics of 'Phenotyping of Obesity Treatment Candidates: A Narrative Review'. Together they form a unique fingerprint.

Cite this